Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
- +86-0635-6175299
- li_ye@inyelchem.com
Shandong Haohong Biotechnology Co., Ltd.
- Home
-
Products
-
- Alectinib Intermediates
- Cabozantinib Intermediates
- Ceritinib Intermediates
- Larotrectinib Intermediates
- Brigatinib Intermediates
- Abemaciclib Intermediates
- Vemurafenib Intermediates
- Ponatinib Intermediates
- Rucaparib Intermediates
- Lenvatinib Intermediates
- Gilteritinib Intermediates
- Pomalidomide Intermediate
- Ruxolitinib Intermediates
- Lenalidomide Intermediates
Active Pharmaceutical Ingredient(API)
- Enzalutamide API
- Apalutamide API
- Cabozantinib API
- Baricitinib API
- Alecitinib API
- Ceritinib API
- Tofacitinib API
- Macitentan API
- Ponatinib API
- Larotrectinib API
- Vemurafenib API
- Gilteritinib API
- Empagliflozin API
- Pomalidomide API
- Regorafenib API
- Palbociclib API
- Regorafenib Hydrate
- Lenalidomide API
- Rivaroxaban API
- Apixaban API
- Ruxolitinib API
- About Us
- News
- Video
- Contact
- Send Inquiry